Search For "sars cov"
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
Scientists develop new mechanism to inactivate COVID-19 virus, block entry
Updated : 3 years, 8 months ago IST
New Delhi [India], July 13 (ANI): Scientists of the Indian Institute of Science (IISc) in collaboration with researchers from the CSIR-Institute of Microbial Technology developed a novel mechanism to inactivate COVID (SARS-CoV-2) virus by blocking their entry to cells and reducing infection
Read More
COVID-19 booster vaccine beneficial for lupus patients: Study
Updated : 3 years, 8 months ago IST
New York [US], July 13 (ANI): Those with systemic lupus erythematosus, or SLE, who received a "booster" dose of the SARS-CoV-2 vaccine after receiving the full dosage are about half as likely to experience a subsequent "breakthrough" COVID-19 infection, according to a recent study.
Read More
Immune response triggered by COVID-19 infection can damage brain
Updated : 3 years, 8 months ago IST
Washington [US], July 6 (ANI): A study from the National Institutes of Health (NIH) said the immune response triggered by COVID-19 infection can damage the brain's blood vessels and may lead to short- and long-term neurological symptoms.
Read More
COVID-19 vaccine activates antibodies that target parts of the virus: Stud
Updated : 3 years, 8 months ago IST
Washington [US], July 5 (ANI): Considering the speculation about whether the SARS-CoV-2 vaccine can reawaken previous antibody responses and pave the way to a universal coronavirus vaccine, new research on a COVID-19 vaccine's antibody response suggests that the immune system's history with
Read More
Study shows development of rapid COVID-19 test by UTSW researchers that ca
Updated : 3 years, 8 months ago IST
Washington [US], July 3 (ANI): Last year, pathologist Jeffrey SoRelle, M.D., and colleagues developed CoVarScan, a rapid COVID-19 test that detects eight hotspot signatures in the SARS-CoV-2 virus. Now that CoVarScan has been tested on more than 4,000 patient samples collected at UT Southwes
Read More
Children below 12 years at lower risk of contracting severe COVID infectio
Updated : 3 years, 8 months ago IST
New Delhi [India] July 2 (ANI): As schools across the country reopened after the summer vacation, there are concerns among parents about their children getting infected with COVID-19 as a surge in cases was witnessed in parts of India.
Read More
Research shows new coronavirus antibody detection method that does not req
Updated : 3 years, 8 months ago IST
Tokyo [Japan], July 1 (ANI): In spite of significant and impressive advances in vaccine technology, the global COVID-19 pandemic is over by any means. An important challenge in limiting the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is identifying the infected ind
Read More
New research on airborne stability and infectivity of SARS-CoV-2 could hel
Updated : 3 years, 8 months ago IST
California [US], June 29 (ANI): Researchers have measured the stability and infectivity of four variants of SARS-CoV-2 in 5-10 um-wide aerosolized droplets over a period of 5 seconds to 20 minutes and found a reduction in infectivity by around 90% after 20 minutes; loss of infectivity was as
Read More
Study suggests glucose meter might soon test SARS-CoV-2 antibody levels
Updated : 3 years, 8 months ago IST
Washington [US], June 19 (ANI): Researchers have reported simple and accurate glucose meter-based tests that include new fusion proteins. They say that consumers will one day be able to use this assay to monitor their SARS-CoV-2 antibody levels.
Read More
INSACOG finds COVID-19's Omicron sub-lineages BA.2, BA.2.38 have caused sp
Updated : 3 years, 9 months ago IST
New Delhi [India], June 18 (ANI): India's COVID genome sequencing facility, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) on Friday has reviewed the genomic surveillance data, where they have found that Omicron sub-lineages majorly BA.2, BA.2.38 and in some parts of the country BA.4
Read More
Glucose meter to soon test for SARS-CoV-2 antibody levels: Study
Updated : 3 years, 9 months ago IST
Washington [US], June 17 (ANI): A commercial COVID test can quickly determine if you are infected with SARS-CoV-2. However, if a positive result is obtained, there is no equivalent home test to assess how long you have been protected from reinfection.
Read More